| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/29/2009 | WO2009014382A2 Cxcl11 adjuvant compositions and uses thereof |
| 01/29/2009 | WO2009014263A1 Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient |
| 01/29/2009 | WO2009014216A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 01/29/2009 | WO2009014207A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | WO2009013972A1 Immunoadjuvant and method of assaying iga antibody |
| 01/29/2009 | WO2009013619A2 The ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 01/29/2009 | WO2009013551A2 Process for preparing viral vaccine |
| 01/29/2009 | WO2009013543A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | WO2009013443A1 Inactivated staphylococcal whole-cell vaccine |
| 01/29/2009 | WO2009013379A1 Attenuated live strain of salmonella enterica serovar choleraesuis as a vaccine and vaccinal vehicle for swine livestock |
| 01/29/2009 | WO2009013097A1 Complexes of grp94 with human immunoglobulin g |
| 01/29/2009 | WO2009013018A2 Compositions and methods for generating an immune response in a subject |
| 01/29/2009 | WO2009012601A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | WO2009012589A1 Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008149225A3 Anti-tumour vaccine comprising full-length wt1 |
| 01/29/2009 | WO2008145074A3 Amino acid and nucleic acid sequences and vaccine to control ectoparasite infestations in fish |
| 01/29/2009 | WO2008144753A3 Antibodies to tnf alpha and use thereof |
| 01/29/2009 | WO2008131575A3 Anti-alk antibodies suitable for treating metastatic cancers or tumors |
| 01/29/2009 | WO2008122441A3 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/29/2009 | WO2008115785A3 Multivalent avian influenza vaccines and methods |
| 01/29/2009 | WO2008085938A3 Antibody inhibiting infection of papillomavirus |
| 01/29/2009 | WO2008070049A3 Peptide and treatment for hiv-1 infection |
| 01/29/2009 | WO2008016431A3 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 01/29/2009 | WO2008014733A9 Medicament for lct poisoning |
| 01/29/2009 | WO2008010101A9 Antagonist antibody against epha2 for the treatment of cancer |
| 01/29/2009 | WO2008004992A3 Transdermal formulations containing hepatitis c virus immunogens and an ethoxylated oil |
| 01/29/2009 | WO2007117964A3 Apparatus and method for vaccine development using ultrasound technology |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | WO2007094986A3 Methods of expressing gam-negative glycosaminoglycosaminoglycan synthase genes in gram-positive hosts |
| 01/29/2009 | US20090029469 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 01/29/2009 | US20090029459 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 01/29/2009 | US20090029457 Pharmaceutical composition for inducing an immune response in a human or animal |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090028956 Polypeptide microparticles |
| 01/29/2009 | US20090028945 Immunoisolative encapsulation system |
| 01/29/2009 | US20090028932 Vaccine formulations for leishmania |
| 01/29/2009 | US20090028909 Intranasal Vaccine for Use Against Disease Caused by Enterotoxigenic Escherichia Coli |
| 01/29/2009 | US20090028908 Methods for treating neurogenic inflammation |
| 01/29/2009 | US20090028907 Botulinum toxin treatment |
| 01/29/2009 | US20090028906 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in a solid form |
| 01/29/2009 | US20090028905 Injecting a Botulinum Toxin into a flexor digitorum profundus muscle of the affected leg of the horse, in an amount insufficient to cause death or paralysis |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028903 Novel use |
| 01/29/2009 | US20090028902 Viral particle comprising delipidated pestivirus viral particle: initiating a positive immune response in a patient; lower cholesterol content; reduced infectivity and enhanced antigenicity |
| 01/29/2009 | US20090028901 use of such proteins in isolating various types of attenuated viruses for the development of vaccine and pharmaceutical formulations; protocols utilizing interferon antagonists, e.g., NS1, to enhance gene therapy or DNA vaccination based on their ability to increase gene expression |
| 01/29/2009 | US20090028900 West nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines |
| 01/29/2009 | US20090028894 Papilloma Virus Capsomere Vaccine Formulations and Methods of Use |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028892 Ostertagia Vaccine |
| 01/29/2009 | US20090028891 Chlamydia Antigens and Uses Thereof |
| 01/29/2009 | US20090028890 encodes an HIV-1 MA polypeptide myristate binding site; capable of selectively eliciting a substantially th-1 immune response to HIV-1; vaccine |
| 01/29/2009 | US20090028889 Novel Polypeptide Ligands For Toll-Like Receptor 2 (TLR2) |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028886 Carrier conjugates of gnrh-peptides |
| 01/29/2009 | US20090028885 Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof |
| 01/29/2009 | US20090028884 Oligomeric receptor ligand pair member complexes |
| 01/29/2009 | US20090028883 Novel P-selectin Ligand Protein |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028881 Conjugate of an antibody against CCR5 and an antifusogenic peptide |
| 01/29/2009 | US20090028880 Serum albumin binding proteins |
| 01/29/2009 | US20090028879 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 01/29/2009 | US20090028878 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 01/29/2009 | US20090028877 Antibody Composition Specifically Binding to Ganglioside Gm |
| 01/29/2009 | US20090028876 Methods of modifying cd11c+ dendritic cell development to form osteoclasts functional in the bone environment |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028874 Synthetic Protein as Tumor-Specific Vaccine |
| 01/29/2009 | US20090028873 Substituted cyclohexanols |
| 01/29/2009 | US20090028872 Human monoclonal antibodies to cd70 |
| 01/29/2009 | US20090028871 Novel use of ligands specific to fex-2 polypeptide |
| 01/29/2009 | US20090028870 Treatment of Hematologic Disorders |
| 01/29/2009 | US20090028869 Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| 01/29/2009 | US20090028868 Anti-cancer pharmaceutical compositions and methods for treating patients with cancer |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028866 USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE |
| 01/29/2009 | US20090028865 Method of treating hepatocellular carcinoma |
| 01/29/2009 | US20090028864 L-amino acid oxidase with cytotoxic activity from aplysia functata |
| 01/29/2009 | US20090028863 Markers for diagnosis of cancer and its use |
| 01/29/2009 | US20090028862 Emmprin antagonists and uses thereof |
| 01/29/2009 | US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 01/29/2009 | US20090028860 Use of IL-17 Expression to Predict Skin Inflammation; Methods of Treatment |
| 01/29/2009 | US20090028859 Bispecific antibodies that bind to vegf receptors |
| 01/29/2009 | US20090028858 Substituted quinoline derivatives |
| 01/29/2009 | US20090028857 Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| 01/29/2009 | US20090028856 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use |
| 01/29/2009 | US20090028855 Inhibitors of akt/pkb with anti-tumor activity |
| 01/29/2009 | US20090028854 sc(Fv)2 SITE-DIRECTED MUTANT |
| 01/29/2009 | US20090028853 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6 |
| 01/29/2009 | US20090028852 Roles For Dual Endothelin-1/Angiotensin II Receptor (DEAR) In Hypertension and Angiogenesis |
| 01/29/2009 | US20090028851 Novel Antibodies Directed to the Mammalian Eag1 Ion Channel Protein |
| 01/29/2009 | US20090028850 Prolongation of survival of an allograft by inhibiting complement activity |
| 01/29/2009 | US20090028849 Agents and methods for inhibition of airway hyperresponsiveness |
| 01/29/2009 | US20090028848 Sequence based engineering and optimization of single chain antibodies |
| 01/29/2009 | US20090028847 Multiple myeloma and al amyloid immunotherapy targeting immunoglobulin light chains and uses thereof |
| 01/29/2009 | US20090028846 Immunoglobulin fractions |
| 01/29/2009 | US20090028845 obtaining a sample from the subject's frontal cortex, analyzing the level of expression of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene, wherein reduced levels of expression of UCH-L1 gene compared to controls is diagnostic of DLB; Alzheimer's Disease and Parkinson's disease |
| 01/29/2009 | US20090028844 Galnts as modifiers of the igfr pathway and methods of use |
| 01/29/2009 | US20090028843 IgA allelic variants |
| 01/29/2009 | US20090028821 Prodrugs of cc-a1065 analogs |